Mitral valve (MV) disease is the most common form of heart valve disease, occurring in approximately 2% of the population and resulting in 43,000 open-chest surgical procedures every year [1]. One subtype is mitral valve prolapse (MVP), which primarily affects the elderly and is often characterized by severe regurgitant flow, thickened and enlarged leaflets, and disrupted and mechanically compromised collagen architecture.
展开▼
